Euphotic

Euphotic is a global health technology venture with Finnish roots, and international partners from USA, Japan, Singapore, Sweden, and Belgium. Our mission is to improve the quality of life of patients suffering from neurological diseases by providing clinicians with useful tools.

Our first product aims to measure cortical excitability noninvasively. The product will help clinicians to prescribe better individualized dosages by quantifying patient?s response to AEDs (anti-epileptic drugs). We believe this quantification will help clinicians to adjust the dosage of AEDs, as well as select the appropriate drug. We expect our product to improve the quality of life of epileptic patients and reduce the time they spend in the hospital.

The Euphotic measurement requires an MEG device, Euphotic IPS (Intermittent Photic Stimulation) stimulator, and Euphotic data analysis service. Euphotic IPS stimulator (patent pending) provides a highly standardized measurement setting, and Euphotic data analysis service outputs the quantified cortical excitability.

For more info, please contact veikko.jousmaki@aalto.fi